InsiderTrades

Form 4 for VYGR Voyager Therapeutics, Inc.

Accepted 2021-11-30 00:00:00 ET · period of report 2021-11-26 · accession 0001104659-21-144995 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2021-11-30 2021-11-26 VYGR Burek Julie VP, Fin A - Grant $0.00 +13.5K 46.5K +41% $0
D 2021-11-30 2021-11-26 VYGR Burek Julie VP, Fin A - Grant $0.00 +25.0K 25.0K New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2021-11-26 A A 13,500 $0.00 46,522 D — — (F1) Consists of shares of common stock issuable under restricted stock units ("RSUs") awarded to the Reporting Person pursuant to the Voyager Therapeutics, Inc. 2015 Stock Option and Incentive Plan (the "2015 Plan"). Each RSU represents the right to receive one share of common stock upon vesting. The vesting commencement date of the RSU award is January 1, 2022. The RSU award vests over three years, with 1/3rd of the shares of common stock underlying the RSU award vesting on the one-year anniversary of such vesting commencement date and an additional 1/3rd of the shares of common stock underlying the RSU award vesting at the end of each successive one-year period thereafter, subject to the Reporting Person's continued service.
2 Derivative Stock Option (Right to Buy) 2021-11-26 A A 25,000 $0.00 25,000 D $3.06 · — to 2031-11-26 25,000 Common Stock (F2) This stock option was issued pursuant to the 2015 Plan. The vesting commencement date of the option is the grant date. The option vests over four years, with 1/48th of the shares of common stock underlying the option vesting upon the one-month anniversary of the option's vesting commencement date and an additional 1/48th of the shares of common stock underlying the option vesting at the end of each successive one-month period thereafter, subject to the Reporting Person's continued service.